Posts Tagged 'big pharma'

First Trial Scheduled in Opioid MDL

Judge Polster schedules opioid MDL for March 2019 startThe judge overseeing the MDL that seeks to hold drug manufacturers and distributors responsible for their roles in the nation’s ongoing opioid abuse epidemic has scheduled the first cases in the litigation for trial. If all goes to plan, some very serious questions might start seeing answers beginning in March of next year.

U.S. District Judge Daniel Polster had, to this point, sought ...

continue reading...

Opioid MDL Judge’s Hopes for Expediency Face Tough Challenges

opioid mdl case may not be as fast as judge had hoped“My objective is to do something meaningful to abate this crisis and to do it in 2018.” These are the words that US District Judge Dan Polster used to open a multi-district litigation brought by municipalities from around the country against the Big Pharma companies they believe have exacerbated the nation’s opioid overdose and addiction crisis.

His goal has been for the parties to reach ...

continue reading...

Judge with No MDL Experience Deemed Unqualified to Preside over Opioid MDL

A former judge and now private practice attorney was openly laughed at during an MDL panel in Illinois when she suggested they should give a nation’s worth of opioid cases to a judge who had never presided over a national litigation.

Ann Callis, formerly a chief judge in Madison County, Illinois and now practicing law privately as an attorney addressed the panel in late November and requested that every opioid-related lawsuit be transferred under U.S. District Judge Staci Yandle. The exchange ...

continue reading...

National Opinion of Big Pharma May Not Be As Bad As Some Might Think

one third of those polled had bad impression of big pharmaIn a recent poll conducted by The Reputation Institute, one-third of respondents viewed the pharmaceutical industry’s reputation as excellent. Conversely, a third saw Big Pharma negatively.

Read this blog and any number of others, and most will come away with the impression that the pharmaceutical industry is a group that is more concerned with profits than public safety. Bonuses and sales numbers take precedence ...

continue reading...